Akari Therapeutics (AKTX) EBT (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -193.77% |
| Dec 31, 2025 | 30.38% |
| Sep 30, 2025 | -136.29% |
| Jun 30, 2025 | 11.48% |
| Mar 31, 2025 | 5.09% |
| Dec 31, 2024 | -30.29% |
| Sep 30, 2024 | 61.39% |
| Jun 30, 2024 | -25.24% |
| Mar 31, 2024 | -17.78% |
| Dec 31, 2023 | -104.05% |
| Sep 30, 2023 | 45.68% |
| Jun 30, 2023 | -0.48% |
| Jun 30, 2022 | -10.93% |
| Mar 31, 2022 | 99.97% |
| Dec 31, 2021 | -1,399,504.66% |
| Sep 30, 2021 | 66.22% |
| Jun 30, 2021 | 21.94% |
| Mar 31, 2021 | 19.52% |
| Dec 31, 2020 | -2,761.96% |
| Sep 30, 2020 | 95.93% |
| Jun 30, 2020 | -19.99% |
| Mar 31, 2020 | 37.04% |
| Dec 31, 2019 | -151.17% |
| Sep 30, 2019 | 48.35% |
| Jun 30, 2019 | -45,623.84% |
| Mar 31, 2019 | 100.28% |
| Dec 31, 2018 | -61.26% |
| Sep 30, 2018 | 63.09% |
| Jun 30, 2018 | -86.56% |
| Mar 31, 2018 | 68.73% |
| Dec 31, 2017 | -59.63% |
| Sep 30, 2017 | -16.19% |
| Jun 30, 2017 | 11.33% |
| Mar 31, 2017 | -179.23% |
| Dec 31, 2016 | 1,144.98% |
| Sep 30, 2016 | 86.73% |
| Jun 30, 2016 | -151.31% |
| Mar 31, 2016 | -105.77% |
| Dec 31, 2015 | 206.21% |
| Sep 30, 2015 | -2,816.56% |
| Jun 30, 2015 | 1.52% |
| Mar 31, 2015 | -52.34% |
| Dec 31, 2014 | -399.18% |
| Sep 30, 2014 | 89.99% |
| Jun 30, 2014 | -28.10% |